Sarepta Therapeutics on Wednesday announced a long-term deal with biotech manufacturer Aldevron for supply GMP-grade plasmids, an effort to support its ambitions for gene therapy.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,